Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

l rate of 51 percent. Subset analyses suggested the greatest benefit occurred in the difficult-to-treat patients with prior myelodysplastic syndrome (MDS) or those that had received prior hypomethylating therapy (HMA). Adverse events were mild, predictable and manageable.

About Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Approximately 14,590 new cases of AML were expected to be diagnosed in the United States in 2013.1 As of January 2008 an estimated 30,993 people were living with (or were in remission from) AML.2 Although AML can occur at any age, adults aged 60 years and older are more likely to develop the disease than younger people. AML is a cancer characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. AML may develop from the progression of other diseases such as myelodysplastic syndrome (MDS), a blood cancer that also affects the bone marrow leading to a decrease in circulating red blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age. The symptoms of AML are caused by replacement of normal bone marrow with leukemic cells, which causes a drop in red blood cells, platelets, and normal white blood cells leading to infections and bleeding. AML progresses rapidly and is typically fatal within weeks or months if left untreated. Although a substantial proportion of younger individuals who develop AML can be cured, AML in the elderly typically responds poorly to standard therapy with few complete remissions.

About CTI
Cell Therapeutics, Inc. (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in Seattle, WA. For additional information and to si
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 5. März 2015 Unfors ... im Bereich diagnostische Röntgenstrahlung, stellte heute ... dem European Congress of Radiology (ECR) ... Österreich, einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor ...
(Date:3/4/2015)... Holdings, Inc. (NYSE: HRC ) announced today ... to its Board of Directors.  She most recently served ... as President of Covidien,s Vascular Therapies Division from 2012 to ... 2012. Ms. Enxing Seng joined Covidien in ... she was a founding member and executive officer responsible ...
(Date:3/4/2015)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... Phase II proof of concept clinical study investigating ... monotherapy in the treatment of chronic pruritus in ... and clinically meaningful improvement from baseline by tradipitant ... a 100mm unit Visual Analog Scale (VAS) for ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7
(Date:3/5/2015)... 2015 Elandas announces the creation of ... the company prepares to announce its next generation product ... in the Life Sciences field. , “Elandas depends on ... Elandas CEO Ryan Roberts. “We have been fortunate to ... our collaborative efforts. As we continue to grow, we ...
(Date:3/4/2015)... The emergence of nanotechnology has ... past decade. The pharmaceutical world has witnessed advancements ... the form of liposomes and polymeric nanoparticles that ... safety and efficiency. In the area of ... upon the enhanced permeability and retention (EPR) effect ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Ultraman Florida ... 6.2 mile swim, 261.4 mile bike, and 52.4 mile ... total time of 24:45:45. , "This race was awesome ... my wonderful team and sponsors for supporting me through ... Florida 2015 had a total of 40 select participants ...
(Date:3/4/2015)... March 04, 2015 TROY Healthcare Solutions ... which provides the ultimate level of security for prescriptions, ... Hilton Houston Plaza Medical Center located at 6633 Travis ... Beginning at 7 AM, TROY Healthcare Solutions will host ... Solutions will offer brief presentations each hour to introduce ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
Breaking Medicine News(10 mins):Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3
... RIO DE JANEIRO, Dec. 9 Amilpar (Bovespa: ... the largest managed,care organization in Brazil, in addition to the ... informs its shareholders and the,market that the initiatives to proceed ... Applicant its subsidiary AMIL ASSISTENCIA MEDICA,INTERNACIONAL LTDA. The filing to ...
... SANTA ROSA, Calif., Dec. 9 Kendall-Jackson Winery today ... for Cancer Research, concluding its five-month-long, online auction of ... from champion racehorse Rachel Alexandra,s historic 2009 racing season. ... The highest-earning single item was the final lot: a ...
... same as last year, survey shows , WEDNESDAY, Dec. 9 (HealthDay ... of the flu in general, there has been only a slight ... flu shot, a new report shows. , By the middle of ... is recommended had gotten a shot, according to the survey. Seasonal ...
... Dec. 9 The Michigan Minority Business Development Council ... On September 29 at the Detroit Symphony Orchestra/Max Fisher Music ... The theme for this year,s awards was: "Celebrating the ... corporations and individuals who actively include certified minority suppliers in ...
... , SOUTHFIELD, Mich., Dec. 9 Blue Care Network has announced ... be retiring at the end of February after a 33-year career ... Cross Blue Shield of Michigan. , The company will ... , "Jeanne has led the way for Blue Care Network ...
... , ... today announced a C$22.5 million project with the Government of ... of an electronic healthcare records (EHR) system. This technology can ... information, which can improve the efficiency and quality of patient ...
Cached Medicine News:Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2Health News:Seasonal Flu Vaccination Rates Still Too Low 2Health News:Seasonal Flu Vaccination Rates Still Too Low 3Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2Health News:Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 3
... The microprocessor controlled, Blanketrol ... therapy system provides effective patient ... one system! The Blanketrol II ... highest flow rates of any ...
Inquire...
Inquire...
... and accurate immunoassay for the quantification of ... fully automated Elecsys proBNP assay helps to ... NT-proBNP levels also indicate the severity of ... prognosis. In addition, NT-proBNP facilitates monitoring, allowing ...
Medicine Products: